Tetraphase Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tetraphase Pharmaceuticals Inc with three other companies in this sector in the United States: Strongbridge Biopharma plc (2018 sales of $18.03 million of which 93% was Keveyis), Arena Pharmaceuticals, Inc. ($17.97 million of which 100% was Drug Discovery & Development), and Durect Corporation ($18.56 million of which 100% was research, development and manufacturing ).

Sales Analysis. During the year ended December of 2018, sales at Tetraphase Pharmaceuticals Inc were $18.90 million. This is an increase of 95.6% versus 2017, when the company's sales were $9.67 million.